• Something wrong with this record ?

Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer

Y. Liu, CM. Lusk, MH. Cho, EK. Silverman, D. Qiao, R. Zhang, ME. Scheurer, F. Kheradmand, DA. Wheeler, S. Tsavachidis, G. Armstrong, D. Zhu, II. Wistuba, CB. Chow, C. Behrens, CW. Pikielny, C. Neslund-Dudas, SM. Pinney, M. Anderson, E. Kupert, J....

. 2018 ; 13 (10) : 1483-1495. [pub] 20180704

Language English Country United States

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't

Grant support
R01 CA092824 NCI NIH HHS - United States
R01 HL110883 NHLBI NIH HHS - United States
U19 CA203654 NCI NIH HHS - United States
U19 CA148127 NCI NIH HHS - United States
HHSN268201200007C NHLBI NIH HHS - United States
HHSN261201300011I NCI NIH HHS - United States
P30 CA125123 NCI NIH HHS - United States
K01 HL129039 NHLBI NIH HHS - United States
R01 CA134433 NCI NIH HHS - United States
R01 CA141769 NCI NIH HHS - United States
R01 CA080127 NCI NIH HHS - United States
U01 CA076293 NCI NIH HHS - United States
P30 CA023108 NCI NIH HHS - United States
R01 CA060691 NCI NIH HHS - United States
HHSN261201300011C CCR NIH HHS - United States
R01 CA134682 NCI NIH HHS - United States
T42 OH008416 NIOSH CDC HHS - United States
R01 CA127219 NCI NIH HHS - United States
R01 HL113264 NHLBI NIH HHS - United States
R01 CA074386 NCI NIH HHS - United States
K07 CA181480 NCI NIH HHS - United States
R01 HL089897 NHLBI NIH HHS - United States
R03 CA077118 NCI NIH HHS - United States
R01 HL089856 NHLBI NIH HHS - United States
R01 HL082487 NHLBI NIH HHS - United States
P50 CA090578 NCI NIH HHS - United States
P20 GM103534 NIGMS NIH HHS - United States
R35 CA197449 NCI NIH HHS - United States
R01 CA084354 NCI NIH HHS - United States
P30 CA022453 NCI NIH HHS - United States
R01 CA087895 NCI NIH HHS - United States
N01HG65404 NHGRI NIH HHS - United States
P30 ES006096 NIEHS NIH HHS - United States

BACKGROUND: Genome-wide association studies are widely used to map genomic regions contributing to lung cancer (LC) susceptibility, but they typically do not identify the precise disease-causing genes/variants. To unveil the inherited genetic variants that cause LC, we performed focused exome-sequencing analyses on genes located in 121 genome-wide association study-identified loci previously implicated in the risk of LC, chronic obstructive pulmonary disease, pulmonary function level, and smoking behavior. METHODS: Germline DNA from 260 case patients with LC and 318 controls were sequenced by utilizing VCRome 2.1 exome capture. Filtering was based on enrichment of rare and potential deleterious variants in cases (risk alleles) or controls (protective alleles). Allelic association analyses of single-variant and gene-based burden tests of multiple variants were performed. Promising candidates were tested in two independent validation studies with a total of 1773 case patients and 1123 controls. RESULTS: We identified 48 rare variants with deleterious effects in the discovery analysis and validated 12 of the 43 candidates that were covered in the validation platforms. The top validated candidates included one well-established truncating variant, namely, BRCA2, DNA repair associated gene (BRCA2) K3326X (OR = 2.36, 95% confidence interval [CI]: 1.38-3.99), and three newly identified variations, namely, lymphotoxin beta gene (LTB) p.Leu87Phe (OR = 7.52, 95% CI: 1.01-16.56), prolyl 3-hydroxylase 2 gene (P3H2) p.Gln185His (OR = 5.39, 95% CI: 0.75-15.43), and dishevelled associated activator of morphogenesis 2 gene (DAAM2) p.Asp762Gly (OR = 0.25, 95% CI: 0.10-0.79). Burden tests revealed strong associations between zinc finger protein 93 gene (ZNF93), DAAM2, bromodomain containing 9 gene (BRD9), and the gene LTB and LC susceptibility. CONCLUSION: Our results extend the catalogue of regions associated with LC and highlight the importance of germline rare coding variants in LC susceptibility.

Channing Division of Network Medicine Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts

Dan L Duncan Comprehensive Cancer Center Department of Medicine Baylor College of Medicine Houston Texas

Department of Biomedical Data Science Geisel School of Medicine Dartmouth College Lebanon New Hampshire

Department of Molecular and Human Genetics Human Genome Sequence Center Baylor College of Medicine Houston Texas

Department of Pediatrics Baylor College of Medicine Houston Texas

Department of Public Health Sciences Henry Ford health System Detroit Michigan

Department of Thoracic Head and Neck Medical Oncology The University of Texas M D Anderson Cancer Center Houston Texas

Department of Translational Molecular Pathology The University of Texas M D Anderson Cancer Center Houston Texas

Faculty of Health Sciences Palacky University Olomouc Czech Republic

Harvard University School of Public Health Boston Massachusetts

Houston Texas

Institute for Clinical and Translational Research Baylor College of Medicine Houston Texas

Institute of Public Health and Preventive Medicine Charles University 2nd Faculty of Medicine Prague Czech Republic

International Agency for Research on Cancer Lyon France

International Organization for Cancer Prevention and Research Belgrade Serbia

Karmanos Cancer Institute Wayne State University Detroit Michigan

Louisiana State University Health Sciences Center New Orleans Louisiana

Lunenfeld Tanenbaum Research Institute Sinai Health System Toronto Ontario Canada

Maria Sklodowska Curie Institute of Oncology Center Warsaw Poland

Mayo Clinic College of Medicine Rochester Minnesota

Medical College of Wisconsin Milwaukee Wisconsin

Michael E DeBakey Veterans Affairs Medical Center

National Human Genome Research Institute Bethesda Maryland

National Institute of Public Health Bucharest Romania

Nofer Institute of Occupational Medicine Department of Environmental Epidemiology Lodz Poland

Princess Margaret Cancer Center Toronto Ontario Canada

Roy Castle Lung Cancer Research Programme The University of Liverpool Department of Molecular and Clinical Cancer Medicine Liverpool United Kingdom

Russian N N Blokhin Cancer Research Centre Moscow Russian Federation

The University of Toledo College of Medicine Toledo Ohio

University of Cincinnati College of Medicine Cincinnati Ohio

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035139
003      
CZ-PrNML
005      
20191015105944.0
007      
ta
008      
191007s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jtho.2018.06.016 $2 doi
035    __
$a (PubMed)29981437
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Liu, Yanhong $u Dan L. Duncan Comprehensive Cancer Center, Department of Medicine, Baylor College of Medicine, Houston, Texas. Electronic address: yl10@bcm.edu.
245    10
$a Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer / $c Y. Liu, CM. Lusk, MH. Cho, EK. Silverman, D. Qiao, R. Zhang, ME. Scheurer, F. Kheradmand, DA. Wheeler, S. Tsavachidis, G. Armstrong, D. Zhu, II. Wistuba, CB. Chow, C. Behrens, CW. Pikielny, C. Neslund-Dudas, SM. Pinney, M. Anderson, E. Kupert, J. Bailey-Wilson, C. Gaba, D. Mandal, M. You, M. de Andrade, P. Yang, JK. Field, T. Liloglou, M. Davies, J. Lissowska, B. Swiatkowska, D. Zaridze, A. Mukeriya, V. Janout, I. Holcatova, D. Mates, S. Milosavljevic, G. Scelo, P. Brennan, J. McKay, G. Liu, RJ. Hung, DC. Christiani, AG. Schwartz, CI. Amos, MR. Spitz,
520    9_
$a BACKGROUND: Genome-wide association studies are widely used to map genomic regions contributing to lung cancer (LC) susceptibility, but they typically do not identify the precise disease-causing genes/variants. To unveil the inherited genetic variants that cause LC, we performed focused exome-sequencing analyses on genes located in 121 genome-wide association study-identified loci previously implicated in the risk of LC, chronic obstructive pulmonary disease, pulmonary function level, and smoking behavior. METHODS: Germline DNA from 260 case patients with LC and 318 controls were sequenced by utilizing VCRome 2.1 exome capture. Filtering was based on enrichment of rare and potential deleterious variants in cases (risk alleles) or controls (protective alleles). Allelic association analyses of single-variant and gene-based burden tests of multiple variants were performed. Promising candidates were tested in two independent validation studies with a total of 1773 case patients and 1123 controls. RESULTS: We identified 48 rare variants with deleterious effects in the discovery analysis and validated 12 of the 43 candidates that were covered in the validation platforms. The top validated candidates included one well-established truncating variant, namely, BRCA2, DNA repair associated gene (BRCA2) K3326X (OR = 2.36, 95% confidence interval [CI]: 1.38-3.99), and three newly identified variations, namely, lymphotoxin beta gene (LTB) p.Leu87Phe (OR = 7.52, 95% CI: 1.01-16.56), prolyl 3-hydroxylase 2 gene (P3H2) p.Gln185His (OR = 5.39, 95% CI: 0.75-15.43), and dishevelled associated activator of morphogenesis 2 gene (DAAM2) p.Asp762Gly (OR = 0.25, 95% CI: 0.10-0.79). Burden tests revealed strong associations between zinc finger protein 93 gene (ZNF93), DAAM2, bromodomain containing 9 gene (BRD9), and the gene LTB and LC susceptibility. CONCLUSION: Our results extend the catalogue of regions associated with LC and highlight the importance of germline rare coding variants in LC susceptibility.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická variace $x genetika $7 D014644
650    _2
$a celogenomová asociační studie $x metody $7 D055106
650    _2
$a lidé $7 D006801
650    _2
$a nádory plic $x genetika $x patologie $7 D008175
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a Research Support, N.I.H., Intramural $7 D052060
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lusk, Christine M $u Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.
700    1_
$a Cho, Michael H $u Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
700    1_
$a Silverman, Edwin K $u Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
700    1_
$a Qiao, Dandi $u Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
700    1_
$a Zhang, Ruyang $u Harvard University School of Public Health, Boston, Massachusetts.
700    1_
$a Scheurer, Michael E $u Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
700    1_
$a Kheradmand, Farrah $u Dan L. Duncan Comprehensive Cancer Center, Department of Medicine, Baylor College of Medicine, Houston, Texas; Michael E. DeBakey Veterans Affairs Medical Center; Houston, Texas.
700    1_
$a Wheeler, David A $u Department of Molecular and Human Genetics, Human Genome Sequence Center, Baylor College of Medicine, Houston, Texas.
700    1_
$a Tsavachidis, Spiridon $u Dan L. Duncan Comprehensive Cancer Center, Department of Medicine, Baylor College of Medicine, Houston, Texas.
700    1_
$a Armstrong, Georgina $u Dan L. Duncan Comprehensive Cancer Center, Department of Medicine, Baylor College of Medicine, Houston, Texas.
700    1_
$a Zhu, Dakai $u Dan L. Duncan Comprehensive Cancer Center, Department of Medicine, Baylor College of Medicine, Houston, Texas; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas.
700    1_
$a Wistuba, Ignacio I $u Department of Translational Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
700    1_
$a Chow, Chi-Wan B $u Department of Translational Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
700    1_
$a Behrens, Carmen $u Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
700    1_
$a Pikielny, Claudio W $u Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire.
700    1_
$a Neslund-Dudas, Christine $u Department of Public Health Sciences, Henry Ford health System, Detroit, Michigan.
700    1_
$a Pinney, Susan M $u University of Cincinnati College of Medicine, Cincinnati, Ohio.
700    1_
$a Anderson, Marshall $u University of Cincinnati College of Medicine, Cincinnati, Ohio.
700    1_
$a Kupert, Elena $u University of Cincinnati College of Medicine, Cincinnati, Ohio.
700    1_
$a Bailey-Wilson, Joan $u National Human Genome Research Institute, Bethesda, Maryland.
700    1_
$a Gaba, Colette $u The University of Toledo College of Medicine, Toledo, Ohio.
700    1_
$a Mandal, Diptasri $u Louisiana State University Health Sciences Center, New Orleans, Louisiana.
700    1_
$a You, Ming $u Medical College of Wisconsin, Milwaukee, Wisconsin.
700    1_
$a de Andrade, Mariza $u Mayo Clinic College of Medicine, Rochester, Minnesota.
700    1_
$a Yang, Ping $u Mayo Clinic College of Medicine, Rochester, Minnesota.
700    1_
$a Field, John K $u Roy Castle Lung Cancer Research Programme, The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Liverpool, United Kingdom.
700    1_
$a Liloglou, Triantafillos $u Roy Castle Lung Cancer Research Programme, The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Liverpool, United Kingdom.
700    1_
$a Davies, Michael $u Roy Castle Lung Cancer Research Programme, The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Liverpool, United Kingdom.
700    1_
$a Lissowska, Jolanta $u Maria Sklodowska-Curie Institute of Oncology Center, Warsaw, Poland.
700    1_
$a Swiatkowska, Beata $u Nofer Institute of Occupational Medicine, Department of Environmental Epidemiology, Lodz, Poland.
700    1_
$a Zaridze, David $u Russian N. N. Blokhin Cancer Research Centre, Moscow, Russian Federation.
700    1_
$a Mukeriya, Anush $u Russian N. N. Blokhin Cancer Research Centre, Moscow, Russian Federation.
700    1_
$a Janout, Vladimir $u Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic.
700    1_
$a Holcatova, Ivana $u Institute of Public Health and Preventive Medicine, Charles University, Second Faculty of Medicine, Prague, Czech Republic.
700    1_
$a Mates, Dana $u National Institute of Public Health, Bucharest, Romania.
700    1_
$a Milosavljevic, Sasa $u International Organization for Cancer Prevention and Research, Belgrade, Serbia.
700    1_
$a Scelo, Ghislaine $u International Agency for Research on Cancer, Lyon, France.
700    1_
$a Brennan, Paul $u International Agency for Research on Cancer, Lyon, France.
700    1_
$a McKay, James $u International Agency for Research on Cancer, Lyon, France.
700    1_
$a Liu, Geoffrey $u Princess Margaret Cancer Center, Toronto, Ontario, Canada.
700    1_
$a Hung, Rayjean J $u Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
700    1_
$a Christiani, David C $u Harvard University School of Public Health, Boston, Massachusetts.
700    1_
$a Schwartz, Ann G $u Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.
700    1_
$a Amos, Christopher I $u Dan L. Duncan Comprehensive Cancer Center, Department of Medicine, Baylor College of Medicine, Houston, Texas; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas.
700    1_
$a Spitz, Margaret R $u Dan L. Duncan Comprehensive Cancer Center, Department of Medicine, Baylor College of Medicine, Houston, Texas.
773    0_
$w MED00186087 $t Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer $x 1556-1380 $g Roč. 13, č. 10 (2018), s. 1483-1495
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29981437 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191015110410 $b ABA008
999    __
$a ok $b bmc $g 1451799 $s 1073689
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 13 $c 10 $d 1483-1495 $e 20180704 $i 1556-1380 $m Journal of thoracic oncology $n J Thorac Oncol $x MED00186087
GRA    __
$a R01 CA092824 $p NCI NIH HHS $2 United States
GRA    __
$a R01 HL110883 $p NHLBI NIH HHS $2 United States
GRA    __
$a U19 CA203654 $p NCI NIH HHS $2 United States
GRA    __
$a U19 CA148127 $p NCI NIH HHS $2 United States
GRA    __
$a HHSN268201200007C $p NHLBI NIH HHS $2 United States
GRA    __
$a HHSN261201300011I $p NCI NIH HHS $2 United States
GRA    __
$a P30 CA125123 $p NCI NIH HHS $2 United States
GRA    __
$a K01 HL129039 $p NHLBI NIH HHS $2 United States
GRA    __
$a R01 CA134433 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA141769 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA080127 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA076293 $p NCI NIH HHS $2 United States
GRA    __
$a P30 CA023108 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA060691 $p NCI NIH HHS $2 United States
GRA    __
$a HHSN261201300011C $p CCR NIH HHS $2 United States
GRA    __
$a R01 CA134682 $p NCI NIH HHS $2 United States
GRA    __
$a T42 OH008416 $p NIOSH CDC HHS $2 United States
GRA    __
$a R01 CA127219 $p NCI NIH HHS $2 United States
GRA    __
$a R01 HL113264 $p NHLBI NIH HHS $2 United States
GRA    __
$a R01 CA074386 $p NCI NIH HHS $2 United States
GRA    __
$a K07 CA181480 $p NCI NIH HHS $2 United States
GRA    __
$a R01 HL089897 $p NHLBI NIH HHS $2 United States
GRA    __
$a R03 CA077118 $p NCI NIH HHS $2 United States
GRA    __
$a R01 HL089856 $p NHLBI NIH HHS $2 United States
GRA    __
$a R01 HL082487 $p NHLBI NIH HHS $2 United States
GRA    __
$a P50 CA090578 $p NCI NIH HHS $2 United States
GRA    __
$a P20 GM103534 $p NIGMS NIH HHS $2 United States
GRA    __
$a R35 CA197449 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA084354 $p NCI NIH HHS $2 United States
GRA    __
$a P30 CA022453 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA087895 $p NCI NIH HHS $2 United States
GRA    __
$a N01HG65404 $p NHGRI NIH HHS $2 United States
GRA    __
$a P30 ES006096 $p NIEHS NIH HHS $2 United States
LZP    __
$a Pubmed-20191007

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...